Intrexon reported $126.26M in Equity Capital and Reserves for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agenus AGEN:US USD -61278000 40.89M
Amgen AMGN:US USD 3.66B 8M
Anika Therapeutics ANIK:US USD 285.56M 626K
Arrowhead Research ARWR:US USD 377.04M 21.48M
AstraZeneca AZN:LN USD 37.04B 1.9B
Bluebird Bio BLUE:US USD 158.86M 21.26M
Gilead Sciences GILD:US USD 21.21B 128M
GlaxoSmithKline GSK:LN GBP 10.6B 1.45B
Heron Therapeutics HRTX:US USD 22.45M 44.19M
Immunogen IMGN:US USD 155.83M 22.18M
Intrexon XON:US USD 126.26M 16.27M
Karyopharm Therapeutics KPTI:US USD -16656000 123.62M
Ligand Pharmaceuticals LGND:US USD 597.48M 218.81M
Macrogenics MGNX:US USD 142.01M 19.06M
Mannkind MNKD:US USD -250538000 12.86M
Novartis NOVN:VX USD 59.34B 1.48B
Peregrine Pharmaceuticals PPHM:US USD 185.4M 4.2M
Rigel Pharmaceuticals RIGL:US USD -13616000 33.45M
Roche Holding ROG:VX 27.99B 2.8B
Sangamo Biosciences SGMO:US USD 294.96M 14.2M
Thermo Fisher Scientific TMO:US USD 44.03B 483M
Veracyte VCYT:US USD 1.08B 27.02M
Xencor XNCR:US USD 727.5M 4.8M
YTE INCY:US USD 4.37B 143.47M
Ziopharm Oncology ZIOP:US USD 38.56M 6.44M